Background/aims: Fibrocytes, circulating cells that co-express markers of haematopoietic stem cells, leucocytes and fibroblast products, traffic to sites of tissue injury, differentiate into myofibroblasts and contribute to wound healing and fibrosis. We investigated the presence of fibrocytes and the expression of their chemotactic pathways CCL21/CCR7 and CXCL12/CXCR4 in proliferative vitreoretinopathy (PVR) epiretinal membranes.
Methods: Sixteen membranes were studied by immunohistochemical techniques.
Results: Cells expressing α-smooth-muscle actin (α-SMA), a marker of differentiation of fibrocytes into myofibroblasts, were present in all membranes. Cells expressing the haematopoietic stem-cell antigen CD34, the leucocyte common antigen CD45, CCR7, CXCR4, CCL21 and CXCL12 were noted in 50%, 75%, 68.8%, 100%, 80% and 93.8% of the membranes, respectively. Double immunohistochemistry indicated that all cells expressing CD34, CD45, CCR7, CXCR4, CCL21 and CXCL12 co-expressed α-SMA. The number of cells expressing CD34 correlated significantly with the numbers of cells expressing CXCL12 (rs = 0.567; p = 0.022) and CCL21 (rs = 0.534; p = 0.04).
Conclusions: Circulating fibrocytes may function as precursors of myofibroblasts in PVR membranes.
Statistics from Altmetric.com
Funding: This work was supported by the College of Medicine, Research Center, King Saud University.
Competing interests: None.
Ethics approval: The study was conducted according to the tenets of the Declaration of Helsinki.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.